Skip to main content
. 2010 Feb 17;95(4):1802–1809. doi: 10.1210/jc.2009-1903

Table 3.

Results of association analysis with femoral neck BMD

SNP Chr Position (bp)a Geneb Minor allele EA women
AA women
MAFc P value Effectd MAFc P value
rs11914434 3 195,157,275 · T 0.08 7.0E-07 0.11 0.84
rs3805941 6 43,165,559 CUL7/MRPL2/KLC4/PTK7 C 0.37 2.1E-06 + 0.41 0.40
rs9827714 3 128,383,182 LOC729455/C3orf56 C 0.47 6.9E-06 0.43 0.65
rs1826601 16 76,059,687 ADAMTS18 T 0.43 1.0E-05 + 0.34 0.25
rs6459375 6 14,849,285 · G 0.10 1.1E-05 0.29 0.74
rs6667721 1 76,640,441 ST6GALNAC3 A 0.15 1.3E-05 + 0.03 0.70
rs1215494 1 89,839,394 LRRC8B/LRRC8C T 0.36 1.6E-05 + 0.38 0.57
rs333616 8 56,963,551 LYN C 0.43 1.7E-05 0.10 0.78
rs2327672 6 136,269,912 PDE7B A 0.14 1.8E-05 + 0.15 0.82
rs2038016 6 14,845,488 · A 0.10 1.9E-05 0.28 1.00
rs4887348 15 86,372,538 NTRK3 G 0.29 2.2E-05 + 0.10 0.06
rs2627690 4 88,872,640 · T 0.30 2.3E-05 0.25 0.44
rs2152319 1 177,581,980 SOAT1/C1orf125 G 0.42 2.3E-05 + 0.46 0.73
rs1298989 14 91,156,466 CATSPERB T 0.25 2.7E-05 + 0.37 0.006e
rs1285635 14 91,158,608 CATSPERB A 0.25 3.0E-05 + 0.38 0.003e
rs8090593 18 69,667,938 · G 0.37 3.1E-05 0.10 0.40
rs2472793 6 14,856,654 · T 0.10 3.2E-05 0.40 0.93
rs4651024 1 177,578,725 SOAT1/C1orf125 T 0.49 3.3E-05 + 0.40 0.85
rs4712240 6 14,860,852 · C 0.10 3.6E-05 0.21 0.32
rs2505780 10 86,450,149 LOC648354 G 0.45 3.6E-05 0.50 0.25
rs1591687 9 105,219,667 · A 0.04 3.6E-05 + 0.17 0.41
rs4240241 4 37,443,327 · G 0.04 3.6E-05 0.29 0.28
rs13336488 16 76,197,733 · G 0.05 3.7E-05 + 0.09 0.97
rs6479168 9 105,217,183 · T 0.04 3.78E-05 + 0.17 0.52
rs11722802 4 28,332,952 · A 0.25 3.9E-05 + 0.04 0.29
rs6443126 3 7,826,708 · T 0.49 4.0E-05 0.29 0.48
rs2637502 5 124,792,046 · A 0.49 4.0E-05 + 0.19 0.07
rs9563646 13 58,232,735 · C 0.33 4.1E-05 + 0.32 0.27
rs11651617 17 14,351,933 · G 0.21 4.3E-05 0.23 0.63
rs2323284 17 14,350,891 · T 0.21 4.3E-05 0.33 0.90
rs2080115 17 14,345,391 · G 0.19 5.2E-05 0.19 0.53
rs7783471 7 51,958,833 · A 0.07 5.3E-05 + 0.09 0.75
rs1360003 9 77,473,244 · C 0.25 5.3E-05 0.30 0.24
rs489659 18 7,547,909 PTPRM G 0.17 6.2E-05 + 0.33 0.05
rs772492 4 90,591,589 · T 0.32 6.3E-05 + 0.28 0.85
rs10223929 7 48,374,319 ABCA13 A 0.10 7.2E-05 0.03 0.42
rs8057501 16 76,116,178 · G 0.39 7.5E-05 + 0.40 0.88
rs2126650 4 88,929,611 IBSP/MEPE A 0.28 7.7E-05 0.08 0.38
rs1431381 18 6,802,509 ARHGAP28 A 0.12 7.8E-05 + 0.03 0.46
rs4686162 3 7,833,150 · C 0.21 8.8E-05 + 0.06 0.02
rs1385320 16 76,099,924 · A 0.41 1.1E-04 + 0.39 0.69
rs1873873 11 128,984,385 LOC731658 C 0.48 1.1E-04 + 0.48 0.52
rs6654021 X 17,665,929 NHS/SCML1 G 0.01 NA NA 0.49 0.77
rs12387240 X 143,324,556 · A 0.16 NA NA 0.13 0.61
rs2006793 X 29,394,774 IL1RAPL1 G 0.49 NA NA 0.10 0.61
rs1801412 X 114,048,960 HTR2C G 0.04 NA NA 0.01 0.32
a

Position obtained from build 130; 

b

defined as any gene within 25 kb of the SNP. If there is no gene within 25 kb of the SNP, a dot (.) is indicated; 

c

minor allele frequency; 

d

+, minor allele increases BMD; 

e

direction of effect is the same as in the GWAS cohort; bold P value indicates P value less than adjusted replication threshold.